Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 177

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Nuciferine ameliorates hepatic steatosis in high‐fat diet/streptozocin‐induced diabetic mice through a PPARα/PPARγ coactivator‐1α pathway

Open access
Zhang, Chao, Deng, Jianjun, Liu, Dan, Tuo, Xingxia, Xiao, Lei, Lai, Baochang, Yao, Qinyu, Liu, Jia, Yang, Haixia, Wang, Nanping · 2018 · British Journal of Pharmacology

Abstract

Background and Purpose: Nuciferine, an alkaloid found in Nelumbo nucifera leaves, alleviates dyslipidemia in vivo. However, whether it improves liver injury in diabetic conditions and the underlying mechanism is unclear. The present study aimed to investigate the effects of nuciferine on lipid and glucose metabolism in a murine model of Type 2 diabetes mellitus (T2DM) and to determine the underlying mechanisms of these effects. Experimental Approach: A murine model of T2DM was induced by high‐fat diet (HFD) feeding combined with streptozocin (STZ) injections, and the diabetic mice were treated with nuciferine in their food. The underlying mechanism of the anti‐steatotic effect of nuciferine was further explored in HepG2 hepatocytes cultured with palmitic acid. Major signalling profiles involved in fatty acid oxidation were then evaluated, using Western blot, RT‐qPCR and si‐RNA techniques, along with immunohistochemistry. Key Results: Nuciferine restored impaired glucose tolerance and insulin resistance in diabetic mice. Hepatic levels of total cholesterol, triglycerides and LDL were decreased, as were the number of lipid droplets, by nuciferine treatment. Furthermore, nuciferine up‐regulated β‐oxidation related genes in livers of diabetic mice. Luciferase reporter cell assay showed that nuciferine directly reversed palmitic acid‐induced inhibition of PPARα transcriptional activity. Silencing PPARγ coactivator‐1α (PGC1α) expression in HepG2 cells abolished the effects of nuciferine in accelerating β‐oxidation. Conclusions and Implications: Nuciferine improved lipid profile and attenuated hepatic steatosis in HFD/STZ‐induced diabetic mice by activating the PPARα/PGC1α pathway. Nuciferine may be a potentially important candidate in improving hepatic steatosis and the management of T2DM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.14482

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 177

Metadata

Authors
Zhang, C., Deng, J., Liu, D., Tuo, X., Xiao, L., Lai, B., Yao, Q., Liu, J., Yang, H., & Wang, N.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2018-10-11
Volume
175
Issue
22
Pages
4218-4228
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2898942138
Cited by
177
References
12
FWCI
10.92
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nuciferine ameliorates hepatic steatosis in high‐fat diet/streptozocin‐induced diabetic mice through a PPARα/PPARγ coactivator‐1α pathway. https://app.cochat.ai/papers/10.1111/bph.14482
The paper
Zhang, C., Deng, J., Liu, D., Tuo, X., Xiao, L., Lai, B., Yao, Q., Liu, J., Yang, H., & Wang, N. (2018). Nuciferine ameliorates hepatic steatosis in high‐fat diet/streptozocin‐induced diabetic mice through a PPARα/PPARγ coactivator‐1α pathway. British Journal of Pharmacology. https://doi.org/10.1111/bph.14482

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.